There is strong correspondence between high Osteopontin and lower mean survival time in tumor (82%) and plasma (100%) measurements, with large mean differences in survival times, indicating a useful role for Osteopontin in patient stratification, Patient survival is largely determined by tumor aggressiveness. Here, SPP1 is linked to neoplasm.